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Dipping into the Cytosol to Broaden
the MHC Class II Peptide Repertoire
A new study by Zhou et al. (2005) in this issue of Im- (
munity explores how cytoplasmic autoantigens gain s
access to the MHC class II antigen-processing path-
p
way. Their experiments show that hsc70 and Lamp-2a
l
mediate antigen transport into endosomal compart-
p
ments for presentation by MHC class II.
s
p
The immune system employs a “divide and conquer”
oapproach to deal with the distinct challenges posed by
fbacterial and viral infections. Viral proteins produced in
tthe cytoplasm (endogenous antigens) are degraded by
tproteasomes into peptides that are shuttled into the ER
mand loaded onto waiting MHC class I (MHCI) molecules
ffor presentation to CD8+ T cells at the cell surface.
Engulfed bacteria and soluble antigens (exogenous an-
atigens), on the other hand, are directed into the endoso-
hmal/lysosomal pathway for degradation. The late endo-
asomal compartments of the cell have been coopted for
guse by the MHC class II (MHCII) antigen-processing
bsystem. Protein fragments derived from the bacterial
aproteins interact with MHCII molecules and are further
ctrimmed into peptides for presentation to CD4+ T cells.
pThis segregation of labor is not simply a matter of con-
dvenience but rather a fundamental aspect of the T cell
wresponse; MHCI-restricted CD8+ T cells have the ma-
tchinery to directly kill virally infected cells, whereas
cMHCII-restricted CD4+ T cells are wired to help B cells
wgenerate neutralizing antibodies against invading bac-
eteria. The synchrony of the system is an intellectually
pleasing aspect of an otherwise rather chaotic adaptive
dimmune system.
cFor over a decade, however, it has been recognized
vthat peptides derived from cytoplasmic and even
pnuclear antigens can find their way onto MHCII mole-
scules (Chicz et al., 1993). At first, these findings were
hregarded simply as “leakiness” in the experimental sys-
2tem, perhaps due to endosomal uptake of cytoplasmic
nantigens from apoptotic cells or cellular debris in the
ocultures. Accumulating data, however, showing specific
iCD4+ T cell responses against viral antigens as well as
pagainst cytoplasmic tumor antigens have forced immu-
Cnologists to consider an alternate pathway(s) for the
rgeneration of MHCII peptide ligands. One of the ap-
wpealing aspects of antigen presentation is that, both for
oMHCI and MHCII, the process follows an orderly path-
iway involving specialized accessory proteins that facili-
ktate antigen fragmentation, transport, and/or loading.
fThe details of a specific alternative pathway for gener-
wating MHCII peptide complexes from cytosolic anti-
sgens, however, have remained obscure.
oThe first clues to the critical players came from
pbreakthrough findings from Fred Dice’s laboratory,
which described a process called chaperone-mediated
oautophagy (CMA) (Chiang et al., 1989; Cuervo and Dice,
1996). CMA results in the transport of cytosolic proteins Mirectly into late endosomal and lysosomal compart-
ents (Majeski and Dice, 2004). CMA substrates resid-
ng in the cytoplasm of cells are recognized and bound
y a molecular chaperone complex that includes the
onstitutive form of the heat shock 70 kDa protein
hsc70) complexed with several other cytoplasmic heat
hock and heat shock-related proteins. The substrate
rotein and chaperone complex are recognized by the
ysosome-associated protein type 2a (Lamp-2a) and
ulled into the lysosomal lumen with the aid of lyso-
omal hsc70 for subsequent degradation by resident
roteases. In humans, there are two different isoforms
f Lamp-2 (Lamp-2a and Lamp-2b), which arise by dif-
erential mRNA splicing. The differences are limited to
he transmembrane region and cytosolic tails; impor-
antly, only Lamp-2a mediates CMA. Remarkably, esti-
ates indicate that this pathway may be responsible
or the degradation of w30% of all cytosolic proteins.
In studies presented in this issue of Immunity, Blum
nd colleagues asked if the CMA pathway might also
ave a role in the adaptive immune response (Zhou et
l., 2005). They reasoned that delivery of cytosolic anti-
ens into late endosomal and lysosomal compartments
y CMA might be crucial for presentation of these
ntigens by MHCII, which also resides within these
ompartments. In these studies, the processing and
resentation of the cytosolic autoantigens glutamate
ecarboxylase (GAD) and a mutant form of Ig κ (SMA)
ere followed after expression of the autoantigens in
ransfected Epstein-Barr virus-transformed human B
ell lines. Processing and presentation was detected
ith HLA-DR4-restricted T cell hybridomas specific for
pitopes from GAD and SMA.
In cells where Lamp-2 protein levels were knocked
own by using antisense cDNA, the presentation of
ytoplasmic GAD was significantly decreased. Con-
ersely, in experiments in which Lamp-2a was overex-
ressed, cytoplasmic GAD and SMA presentation was
ignificantly increased. Overexpression of Lamp-2b,
owever, had no measurable effect. Importantly, Lamp-
a overexpression did not alter MHCII levels, exoge-
ous antigen presentation, overall cellular morphology,
r lysosomal protease maturation or distribution, show-
ng the specificity of Lamp-2a overexpression on cyto-
lasmic antigen processing. To further implicate the
MA pathway in cytoplasmic antigen processing, the
ole of hsc70 in cytoplasmic MHCII antigen processing
as examined. Similar to the results from the analysis
f Lamp-2a, overexpression of cellular hsc70 resulted
n a significant increase in GAD presentation, whereas
nockdown of hsc70 protein levels resulted in a signi-
icant decrease in GAD presentation. These results
ere unexpected given the high constitutive expres-
ion of hsc70 in the cells; and they imply that the levels
f this chaperone are nonetheless limiting for the CMA
rocess.
Finally, this manuscript further investigates the nature
f the substrate of the hsc70/Lamp-2a pathway for
HCII presentation. Previous studies from the Blum
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537laboratory examined the role of the proteasome and the
cytosolic protease calpain by the use of specific inhibi-
tors (Lich et al., 2000). Presentation of cytoplasmic GAD
was selectively blocked by these agents compared to
control, nontreated cells, suggesting that GAD was at
least partially and perhaps completely degraded into
peptides in the cytoplasm prior to transport. In the cur-
rent study, the need for proteolysis was completely by-
passed by delivering the GAD273–285 peptide directly
into the cytoplasm of cells by electroporation. As was
seen after expression of the GAD protein upon trans-
fection, B cells presented the GAD273–285 peptide signif-
icantly better when overexpressing Lamp-2a, indicating
that processed peptides can be a substrate for the
hsc70/Lamp-2a pathway. Dice and colleagues, how-
ever, have previously shown that proteolysis of the sub-
strate proteins does not occur prior to lysosomal im-
port. This is actually consistent with data from the
current paper showing that full-length GAD can be co-
precipitated with both hsc70 and Lamp-2. Clearly, the
nature of the in vivo substrate for the hsc70/Lamp-2a
pathway of MHCII presentation warrants further study.
Recently, other alternative pathways for delivering
antigens into the MHCII pathway have been described.
For example, presentation of peptides derived from en-
dogenous Epstein-Barr virus was shown to be depen-
dent on autophagy (Paludan et al., 2005), and a protea-
some/transporter associated with antigen processing
(TAP)-dependent pathway was shown to be important
for presentation of peptides from influenza virus (Tewari
et al., 2005). Therefore, it is reasonable to propose that
presentation of cytosolic and nuclear antigens is an im-
portant mechanism for generating CD4+ T cell epi-
topes. The overall impact of these pathways on im-
mune function would appear to broaden the possible
peptide repertoire available for initiating T cell re-
sponses. The potential benefits of this are clear for the
two systems that describe processing and presentation
of viral-derived peptides. The adaptive immune system
is always teetering on the edge of autoimmunity, how-
ever, and the presentation of additional self-antigens
may exacerbate this problem. Indeed, the studies pre-sented here focus on the presentation of a peptide de-
rived from GAD, a major autoantigen for type 1 diabe-
tes. In turn, presentation of altered self-antigens via
these pathways may be critical for generating antitu-
mor responses, as has been seen for T cell responses
against melanoma antigens (Wang et al., 1999). Finally,
it seems likely that similar mechanisms must be in
place for intrathymic negative selection that is medi-
ated primarily by dendritic cells and medullary epithelial
cells. Because central tolerance is clearly critical for
preventing autoimmunity, the greater the breadth of
self-antigens that are presented would seem to be of a
significant benefit.
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